Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.48 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | VHL | P40337 | 1/20 | 0.37 |
| ▸ | ELOC | Q15369 | 1/20 | 0.37 |
| ▸ | ELOB | Q15370 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6704209 | 0.82 | THRB (0.44) | KMT2ALTA4HTHRATHRB | |
| SCHEMBL10599649 | 0.82 | KMT2A (0.58) | TSHRKMT2ATHRATHRBLMNA | |
| SCHEMBL13619944 | 0.81 | CA2 (0.50) | TSHRKMT2ACA12CA1CA2 | |
| SCHEMBL56361 | 0.81 | MAPT (0.40) | KMT2ALMNAHPGDSMN1; SMN2 | |
| SCHEMBL5507106 | 0.80 | ESR1 (0.44) | PRSS1PRSS2PRSS3KMT2ACA2 | |
| SCHEMBL609815 | 0.80 | KMT2A (0.39) | TSHRKMT2ATHRATHRBLMNA | |
| SCHEMBL1362104 | 0.80 | ALDH1A1 (0.54) | KMT2ATHRATHRBSMN1; SMN2 | |
| SCHEMBL6844069 | 0.79 | PRSS1 (0.52) | PRSS1PRSS2PRSS3NOS3NOS1 | |
| SCHEMBL2132508 | 0.78 | CA1 (0.50) | KMT2ACA1CA2THRATHRB | |
| SCHEMBL2399333 | 0.78 | LOXL2 (0.52) | NOS3NOS1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4656641-A2 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | University of Southern California (US) | 2025-12-03 | — | — | EP | claimed |
| EP-4374929-B1 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | UNIV SOUTHERN CALIFORNIA (US) | 2025-09-03 | — | — | EP | claimed |
| EP-4374929-A2 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | University of Southern California (US) | 2024-05-29 | — | — | EP | claimed |
| US-20200237697-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES AND METHODS OF USE | UNIVERSITY OF SOUTHERN CALIFORNIA | 2020-07-30 | — | — | US | claimed |
| US-20200170961-A1 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | Neonc Technologies, Inc. | 2020-06-04 | — | — | US | claimed |
| CN-110769831-A | Pharmaceutical compositions comprising POH derivatives and methods of use | 尼昂克技术公司 | 2020-02-07 | — | — | CN | claimed |
| US-20180280317-A1 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | NEONC TECH INC (US) | 2018-10-04 | — | — | US | claimed |
| US-9987237-B2 | Methods and devices for using isoperillyl alcohol | Neonc Technologies, Inc. (US) | 2018-06-05 | — | — | US | claimed |
| CN-105616391-A | Methods and devices for using isoperillyl alcohol | NEO ONCOLOGY INC | 2016-06-01 | — | — | CN | claimed |
| US-20150359754-A1 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | UNIVERSITY OF SOUTHERN CALIFORNIA | 2015-12-17 | — | — | US | claimed |
| US-20130331422-A1 | METHODS AND DEVICES FOR USING ISOPERILLY ALCOHOL | NEONC TECHNOLOGIES INC. (US) | 2013-12-12 | — | — | US | claimed |
| EP-4656641-A2 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | University of Southern California (US) | 2025-12-03 | — | — | EP | disclosed |
| EP-4374929-B1 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | UNIV SOUTHERN CALIFORNIA (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4374929-A2 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | University of Southern California (US) | 2024-05-29 | — | — | EP | disclosed |
| WO-2024080062-A1 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE | テクノＵＭＧ株式会社 | 2024-04-18 | — | — | WO | disclosed |
| EP-1386904-A1 | Acenaphthylene derivative, polymer, and antireflection film-forming composition | JSR Corporation (JP) | 2004-02-04 | — | — | EP | disclosed |
| US-6441160-B2 | HYDROPHOBIC INTERACTION CHROMATOGRAPHY USING PACKING MATERIAL WITH FUNCTIONAL GROUP INTRODUCED TO ADSORB NUCLEIC ACIDS THAT EXHIBIT CERTAIN HYDROPHOBICITY | TOSOH CORPORATION (JP) | 2002-08-27 | — | — | US | disclosed |
| US-20010007026-A1 | METHOD OF SEPARATING NUCLEIC ACIDS BY MEANS OF LIQUID CHROMATOGRAPHY | TOSOH CORPORATION (JP) | 2001-07-05 | — | — | US | disclosed |
| US-6124070-A | STABILITY UNDER HIGH HUMIDITY AND AT LOW TEMPERATURE-LOW HUMIDITY, FINE PARTICLE SIZE AND A SHARP PARTICLE DIAMETER DISTRIBUTION; COMPRISING A BINDER RESIN, A COLORANT, A METHANOL-SOLUBLE RESIN HAVING ORGANIC ACID GROUPS | CANON KABUSHIKI KAISHA (JP) | 2000-09-26 | — | — | US | disclosed |
| EP-0964057-A1 | Method for separating nucleic acids by means of liquid chromatography | TOSOH CORPORATION (JP) | 1999-12-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180280317-A1 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | CPT1A, ADH1C, ADH5 | PRSS1 4128/4885PRSS2 3848/4885PRSS3 3106/4885 |
| US-20010007026-A1 | METHOD OF SEPARATING NUCLEIC ACIDS BY MEANS OF LIQUID CHROMATOGRAPHY | DNA2, HNRNPH3, POLRMT | PRSS1 1539/4885PRSS2 486/4885PRSS3 621/4885 |
| US-20200170961-A1 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | CPT1A, ADH1C, ADH5 | PRSS1 4128/4885PRSS2 3848/4885PRSS3 3106/4885 |
| US-20150359754-A1 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | CPT1A, ADH1C, ADH5 | PRSS1 4128/4885PRSS2 3848/4885PRSS3 3106/4885 |
| US-20130331422-A1 | METHODS AND DEVICES FOR USING ISOPERILLY ALCOHOL | ADH1C, CPT1A, ADH5 | PRSS1 4088/4885PRSS2 3954/4885PRSS3 3331/4885 |
| US-20200237697-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES AND METHODS OF USE | ACADVL, CPT1A, ADH5 | PRSS1 2476/4885PRSS2 2627/4885PRSS3 2336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.